107 related articles for article (PubMed ID: 15876872)
1. Inhibition of caspase 9 and not caspase 8 mediated apoptosis may determine clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.
Oudejans JJ; Muris JJ; Meijer CJ
Cell Cycle; 2005 Apr; 4(4):526-8. PubMed ID: 15876872
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.
Muris JJ; Cillessen SA; Vos W; van Houdt IS; Kummer JA; van Krieken JH; Jiwa NM; Jansen PM; Kluin-Nelemans HC; Ossenkoppele GJ; Gundy C; Meijer CJ; Oudejans JJ
Blood; 2005 Apr; 105(7):2916-23. PubMed ID: 15576477
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule XIAP antagonist restores caspase-9 mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cells.
Cillessen SA; Reed JC; Welsh K; Pinilla C; Houghten R; Hooijberg E; Deurhof J; Castricum KC; Kortman P; Hess CJ; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
Blood; 2008 Jan; 111(1):369-75. PubMed ID: 17916749
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the intrinsic apoptosis pathway downstream of caspase-9 activation causes chemotherapy resistance in diffuse large B-cell lymphoma.
Cillessen SA; Hess CJ; Hooijberg E; Castricum KC; Kortman P; Denkers F; Vos W; van de Wiel MA; Schuurhuis GJ; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
Clin Cancer Res; 2007 Dec; 13(23):7012-21. PubMed ID: 18056177
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
[TBL] [Abstract][Full Text] [Related]
6. Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay.
Cillessen SA; Meijer CJ; Ossenkoppele GJ; Castricum KC; Westra AH; Niesten P; Muris JJ; Nijdam HF; van der Hem KG; Flens M; Hooijberg E; Oudejans JJ
Br J Haematol; 2006 Aug; 134(3):283-93. PubMed ID: 16848771
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis resistance and response to chemotherapy in primary nodal diffuse large B-cell lymphoma.
Muris JJ; Meijer CJ; Ossenkoppele GJ; Vos W; Oudejans JJ
Hematol Oncol; 2006 Sep; 24(3):97-104. PubMed ID: 16715473
[TBL] [Abstract][Full Text] [Related]
8. Targeting ubiquitin-activating enzyme induces ER stress-mediated apoptosis in B-cell lymphoma cells.
Best S; Hashiguchi T; Kittai A; Bruss N; Paiva C; Okada C; Liu T; Berger A; Danilov AV
Blood Adv; 2019 Jan; 3(1):51-62. PubMed ID: 30617217
[TBL] [Abstract][Full Text] [Related]
9. Comparison of apoptosis and apoptosis-related gene products between extranodal oral B-cell lymphoma and maxillofacial nodal B-cell lymphoma.
Yin H; Okada N; Takagi M
J Oral Pathol Med; 2001 Mar; 30(3):141-7. PubMed ID: 11271628
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic apoptotic pathway in anaplastic large cell lymphoma.
Oyarzo MP; Drakos E; Atwell C; Amin HM; Medeiros LJ; Rassidakis GZ
Hum Pathol; 2006 Jul; 37(7):874-82. PubMed ID: 16784988
[TBL] [Abstract][Full Text] [Related]
11. Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development.
Kubuschok B; Trepel M
Expert Opin Drug Discov; 2017 Jul; 12(7):733-745. PubMed ID: 28494631
[TBL] [Abstract][Full Text] [Related]
12. Aberrant localization of apoptosis protease activating factor-1 in lipid raft sub-domains of diffuse large B cell lymphomas.
Hirpara JL; Loh T; Ng SB; Chng WJ; Pervaiz S
Oncotarget; 2016 Dec; 7(51):83964-83975. PubMed ID: 27863378
[TBL] [Abstract][Full Text] [Related]
13. Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B-cell lymphomas.
Muris JJ; Ylstra B; Cillessen SA; Ossenkoppele GJ; Kluin-Nelemans JC; Eijk PP; Nota B; Tijssen M; de Boer WP; van de Wiel M; van den Ijssel PR; Jansen P; de Bruin PC; van Krieken JH; Meijer GA; Meijer CJ; Oudejans JJ
Br J Haematol; 2007 Jan; 136(1):38-47. PubMed ID: 17062006
[TBL] [Abstract][Full Text] [Related]
14. Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
Xue K; Gu JJ; Zhang Q; Mavis C; Hernandez-Ilizaliturri FJ; Czuczman MS; Guo Y
J Cancer Res Clin Oncol; 2016 Feb; 142(2):379-87. PubMed ID: 26314218
[TBL] [Abstract][Full Text] [Related]
15. Resistance to Fas-mediated apoptosis in EBV-infected B cell lymphomas is due to defects in the proximal Fas signaling pathway.
Snow AL; Chen LJ; Nepomuceno RR; Krams SM; Esquivel CO; Martinez OM
J Immunol; 2001 Nov; 167(9):5404-11. PubMed ID: 11673559
[TBL] [Abstract][Full Text] [Related]
16. Motexafin gadolinium induces mitochondrially-mediated caspase-dependent apoptosis.
Chen J; Ramos J; Sirisawad M; Miller R; Naumovski L
Apoptosis; 2005 Oct; 10(5):1131-42. PubMed ID: 16151646
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas.
Filipits M; Jaeger U; Simonitsch I; Chizzali-Bonfadin C; Heinzl H; Pirker R
Clin Cancer Res; 2000 Sep; 6(9):3417-23. PubMed ID: 10999723
[TBL] [Abstract][Full Text] [Related]
18. Anti-apoptotic role and clinical relevance of neurotrophins in diffuse large B-cell lymphomas.
Dubanet L; Bentayeb H; Petit B; Olivrie A; Saada S; de la Cruz-Morcillo MA; Lalloué F; Gourin MP; Bordessoule D; Faumont N; Delage-Corre M; Fauchais AL; Jauberteau MO; Troutaud D
Br J Cancer; 2015 Sep; 113(6):934-44. PubMed ID: 26284337
[TBL] [Abstract][Full Text] [Related]
19. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin.
López-Guillermo A; Colomo L; Jiménez M; Bosch F; Villamor N; Arenillas L; Muntañola A; Montoto S; Giné E; Colomer D; Beà S; Campo E; Montserrat E
J Clin Oncol; 2005 Apr; 23(12):2797-804. PubMed ID: 15728226
[TBL] [Abstract][Full Text] [Related]
20. Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling.
Lam LT; Davis RE; Pierce J; Hepperle M; Xu Y; Hottelet M; Nong Y; Wen D; Adams J; Dang L; Staudt LM
Clin Cancer Res; 2005 Jan; 11(1):28-40. PubMed ID: 15671525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
